Search research articles
Contact Us
Filters
Showing results (241-250 of 262) with videos related to
Page
of 27
Sort By:
Physical Review Letters
|
October 4, 2005
Irradiation-induced magnetism in carbon nanostructures
S Talapatra, P G Ganesan, T Kim, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Factor IX inhibition and epitope localization of factor IX inhibitor antibodies in haemophilia B patients with anaphylactoid reactions
M Yamamoto, S Kamisue, Y Sawamoto, et al.
Thrombosis and Haemostasis
|
June 12, 1999
Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain
M Shibata, M Shima, Y Fujimura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
November 1, 1996
[Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII]
M Shima, Y Sawamoto, M Kamisue, et al.
Blood
|
February 7, 2001
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysis
K Nogami, M Shima, J C Giddings, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 24, 1999
No enzyme activity of 25-hydroxyvitamin D3 1alpha-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation
S Kitanaka, A Murayama, T Sakaki, et al.
British Journal of Haematology
|
October 16, 1999
Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect
K Nogami, M Shima, H Nakai, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 17, 2014
Anti-factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation
A Muto, K Yoshihashi, M Takeda, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 17, 2014
Anti-factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation
A Muto, K Yoshihashi, M Takeda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 30, 2016
Successful haemostatic management of replacement of the ascending aorta for type A acute aortic dissection in a patient with mild haemophilia B
M Takeyama, K Nogami, Y Shida, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 262) with videos related to
Sort By:
Page
of 27
Physical Review Letters
|
October 4, 2005
Irradiation-induced magnetism in carbon nanostructures
S Talapatra, P G Ganesan, T Kim, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Factor IX inhibition and epitope localization of factor IX inhibitor antibodies in haemophilia B patients with anaphylactoid reactions
M Yamamoto, S Kamisue, Y Sawamoto, et al.
Thrombosis and Haemostasis
|
June 12, 1999
Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain
M Shibata, M Shima, Y Fujimura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
November 1, 1996
[Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII]
M Shima, Y Sawamoto, M Kamisue, et al.
Blood
|
February 7, 2001
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysis
K Nogami, M Shima, J C Giddings, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 24, 1999
No enzyme activity of 25-hydroxyvitamin D3 1alpha-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation
S Kitanaka, A Murayama, T Sakaki, et al.
British Journal of Haematology
|
October 16, 1999
Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect
K Nogami, M Shima, H Nakai, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 17, 2014
Anti-factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation
A Muto, K Yoshihashi, M Takeda, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 17, 2014
Anti-factor IXa/X bispecific antibody (ACE910): hemostatic potency against ongoing bleeds in a hemophilia A model and the possibility of routine supplementation
A Muto, K Yoshihashi, M Takeda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 30, 2016
Successful haemostatic management of replacement of the ascending aorta for type A acute aortic dissection in a patient with mild haemophilia B
M Takeyama, K Nogami, Y Shida, et al.
Page
of 27